SAN

83.43

0%↓

MRK1

117.75

-1.01%↓

SHL.DE

+0.89%↑

ARGX

752.2

-0.61%↓

FRE

47.76

-0.27%↓

SAN

83.43

0%↓

MRK1

117.75

-1.01%↓

SHL.DE

+0.89%↑

ARGX

752.2

-0.61%↓

FRE

47.76

-0.27%↓

SAN

83.43

0%↓

MRK1

117.75

-1.01%↓

SHL.DE

+0.89%↑

ARGX

752.2

-0.61%↓

FRE

47.76

-0.27%↓

SAN

83.43

0%↓

MRK1

117.75

-1.01%↓

SHL.DE

+0.89%↑

ARGX

752.2

-0.61%↓

FRE

47.76

-0.27%↓

SAN

83.43

0%↓

MRK1

117.75

-1.01%↓

SHL.DE

+0.89%↑

ARGX

752.2

-0.61%↓

FRE

47.76

-0.27%↓

Kodu・Aktsiate loetelu・Nanobiotix

N
Nanobiotix

Suletud

19.48 -2.01

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

19.12

Max

19.68

Põhinäitajad
By Trading Economics
Sissetulek	41M -5.4M
Müük	48M 27M
Kasumimarginaal	-20.208
Töötajad	103
EBITDA	46M 1.1M

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+15.58% upside

Turustatistika
By TradingEconomics
Turukapital	-25M 882M
Eelmine avamishind	21.49
Eelmine sulgemishind	19.48

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bullish Evidence

2.975 / 3.015 Toetus ja vastupanu

Nanobiotix Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

12. dets 2025, 16:42 UTC

Omandamised, ülevõtmised, äriostud

FTC Sues to Block Henkel's $725 Million Deal for Liquid Nails From PE Firm -- 2nd Update

12. dets 2025, 23:49 UTC

Omandamised, ülevõtmised, äriostud

Intel in Talks to Acquire SambaNova in Deal Valued at $1.6B, Bloomberg Reports, Citing Sources

12. dets 2025, 22:52 UTC

Market Talk

Nike Expected to Show Further Momentum in 2Q Results -- Market Talk

12. dets 2025, 22:32 UTC

Tulu

These Stocks Moved the Most Today: Broadcom, Oracle, Fermi, Tilray, Lululemon, Costco, Netskope, and More -- Barrons.com

12. dets 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

12. dets 2025, 20:45 UTC

Tulu

The Best Dividend ETF for Right Now -- and 2026 -- Barrons.com

12. dets 2025, 20:41 UTC

Market Talk

Oil Ends Week Lower As Market Frets About Oversupply -- Market Talk

12. dets 2025, 20:20 UTC

Market Talk

U.S. Natural Gas Futures Post Hefty Weekly Loss -- Market Talk

12. dets 2025, 19:23 UTC

Tulu

Charles Schwab Is Opening New Accounts and Hauling in New Assets Amid Buoyant Stock Market -- Barrons.com

12. dets 2025, 18:35 UTC

Omandamised, ülevõtmised, äriostud

PNC Financial Expects to Close FirstBank Deal On or About Jan. 5, Subject to Satisfaction of Customary Closing Conditions

12. dets 2025, 18:33 UTC

Omandamised, ülevõtmised, äriostud

PNC Receives Regulatory Approvals For Acquisition Of FirstBank >PNC

12. dets 2025, 18:31 UTC

Market Talk

U.S. Oil Rig Count Edges Up by 1 to 414 -- Market Talk

12. dets 2025, 17:49 UTC

Tulu

Tariffs Mean Costco Has Fewer Product Types This Holiday. But It Has Plenty of Pies. -- WSJ

12. dets 2025, 17:34 UTC

Omandamised, ülevõtmised, äriostud

Orange: Closing Subject to Customary Regulatory Approvals, Other Closing Conditions

12. dets 2025, 17:33 UTC

Omandamised, ülevõtmised, äriostud

Orange: Closing of the Transaction Is Expected in the First Half of 2026

12. dets 2025, 17:33 UTC

Omandamised, ülevõtmised, äriostud

Orange: Agreement Confirms the Non-Binding Agreement That Was Previously Announced Oct. 31

12. dets 2025, 17:32 UTC

Omandamised, ülevõtmised, äriostud

Orange: MasOrange Is Spain's Leading Operator in Terms of Customer Base

12. dets 2025, 17:31 UTC

Omandamised, ülevõtmised, äriostud

Orange to Buy the Stake for EU4.25B in Cash

12. dets 2025, 17:24 UTC

Market Talk

Argentina Predicts Record Wheat Crop -- Market Talk

12. dets 2025, 17:20 UTC

Market Talk

Tulu

Tech, Media & Telecom Roundup: Market Talk

12. dets 2025, 17:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

12. dets 2025, 17:18 UTC

Market Talk

Tulu

Broadcom, Oracle Investor Reactions Show High Bar for AI Cos. -- Market Talk

12. dets 2025, 17:09 UTC

Market Talk

Broadcom Investors Were Primed to Sell Shares -- Market Talk

12. dets 2025, 17:09 UTC

Market Talk

Global Equities Roundup: Market Talk

12. dets 2025, 16:47 UTC

Market Talk

Broadcom's Margins Expected to Narrow Due to AI Revenue -- Market Talk

12. dets 2025, 16:39 UTC

Market Talk

Supply Limits, Geopolitical Risk to Support Crude in 2026 -- Market Talk

12. dets 2025, 16:27 UTC

Omandamised, ülevõtmised, äriostud

FTC Sues to Block Henkel's $725M Deal for Liquid Nails From PE Firm -- 2nd Update

12. dets 2025, 16:15 UTC

Tulu

At Costco, Lots of Pie but No Special Dividend. Why the Street Didn't Like the Earnings. -- Barrons.com

12. dets 2025, 15:35 UTC

Tulu

These Stocks Are Moving the Most Today: Broadcom, Oracle, Fermi, Tilray, Lululemon, Costco, Netskope, and More -- Barrons.com

12. dets 2025, 14:46 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

Võrdlus sarnastega

Hinnamuutus

Nanobiotix Prognoos

Hinnasiht

By TipRanks

15.58% tõus

12 kuu keskmine prognoos

Keskmine 23 EUR 15.58%

Kõrge 25 EUR

Madal 21 EUR

Põhineb 3 Wall Streeti analüütiku instrumendi Nanobiotix 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

3 ratings

Osta

Hoia

Müü

Põhineb 3 analüütiku instrumendi Nanobiotix aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

2.975 / 3.015Toetus ja vastupanu

Recent bullish events outweigh bearish events.

Bearish events outweigh bullish events.

There is one bearish event.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Nanobiotix

Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is headquartered in Paris, France.